Yang Qu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Protein purification and stability 3
- Advanced biosensing and bioanalysis techniques 3
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Jianbo Li (6 shared papers)Jie Ren (6 shared papers)Donglu Shi (4 shared papers)Chao Lin (4 shared papers)Jun Qu (6 shared papers)Robert M. Straubinger (3 shared papers)Mengchun Cheng (2 shared papers)Weizhong Yuan (1 shared paper)
- Journals
- Analytical Chemistry (6 papers)Cancer Research (2 papers)Nanoscale (2 papers)Materials Letters (1 paper)China Ocean Engineering (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Yang Qu
37 papers receiving 888 citations
Peers
Comparison fields: 5 of 111
- Biomaterials 279
- Cancer Research 102
- Toxicology 23
- Biomedical Engineering 256
- Drug Discovery 1
Countries citing papers authored by Yang Qu
This map shows the geographic impact of Yang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Qu more than expected).
Fields of papers citing papers by Yang Qu
This network shows the impact of papers produced by Yang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Qu. The network helps show where Yang Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 95 | |
| 2 | 2019 | 79 | |
| 3 | 2012 | 54 | |
| 4 | 2014 | 52 | |
| 5 | 2007 | 51 | |
| 6 | 2015 | 50 | |
| 7 | Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. | 2011 | 49 |
| 8 | 2015 | 45 | |
| 9 | 2016 | 44 | |
| 10 | 2019 | 43 | |
| 11 | 2015 | 43 | |
| 12 | 2017 | 35 | |
| 13 | 2018 | 29 | |
| 14 | 2023 | 23 | |
| 15 | 2019 | 20 | |
| 16 | 2016 | 17 | |
| 17 | miR-26b inhibits total neurite outgrowth, promotes cells apoptosis and downregulates neprilysin in Alzheimer's disease. | 2018 | 17 |
| 18 | 2023 | 15 | |
| 19 | 2012 | 14 | |
| 20 | 2014 | 13 |
About Yang Qu
Yang Qu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Spectroscopy and Cancer Research, having authored 41 papers that have together received 899 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Advanced Proteomics Techniques and Applications (4 papers), Characterization and Applications of Magnetic Nanoparticles (4 papers), Mass Spectrometry Techniques and Applications (4 papers), MicroRNA in disease regulation (4 papers), Protein purification and stability (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Fluid Dynamics Simulations and Interactions (2 papers). The work is most often cited by research in Biomaterials (279 citations), Cancer Research (102 citations), Toxicology (23 citations), Biomedical Engineering (256 citations) and Drug Discovery (1 citation). Yang Qu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jianbo Li, Jie Ren, Donglu Shi, Chao Lin, Jun Qu, Robert M. Straubinger, Mengchun Cheng, Weizhong Yuan, Mengjie Rui and Ximing Xu. Their work appears in journals such as Analytical Chemistry, Cancer Research, Nanoscale, Materials Letters and China Ocean Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.